MedTrace Logo

Copenhagen Prospective Personalized Oncology (CoPPO)

NCT02290522 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2022-10-26

No results posted yet for this study

Summary

Patients with advanced solid tumors referred to the Phase 1 Unit are offered mapping of GA for identification of pts who could benefit from a personalized treatment.

Conditions

  • Unspecified Adult Solid Tumor, Protocol Specific

Interventions

PROCEDURE

Tumor biopsy

Biopsy of lesion for molecular characterization

Sponsors & Collaborators

  • Ulrik Lassen

    lead OTHER

Principal Investigators

  • Ulrik Lassen, MD, PH.D. · Rigshospitalet, Denmark

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02290522 on ClinicalTrials.gov